JACC. CardioOncology
Long-Term Cardiovascular Care After Cytokine Release Syndrome: JACC CardioOncology Primer
By Terol B, Martín-García A, Farmakis D and 4 others.
Abstract
• Grade ≥2 CRS may identify survivors needing long-term cardiovascular follow-up. • Baseline CV risk, CRS severity and acute CV events should guide post-CRS follow-up. • Late CV events may occur despite resolution of acute CRS. • Evidence is limited; harmonised endpoints and datasets must guide surveillance.
Keywords
- CAR-T
- cardio-oncology
- cardiovascular toxicity
- cytokine release syndrome
- survivorship



